Smrdel et al., 2008 - Google Patents
The influence of selected parameters on the size and shape of alginate beads prepared by ionotropic gelationSmrdel et al., 2008
View PDF- Document ID
- 7474542785065122807
- Author
- Smrdel P
- Bogataj M
- Mrhar A
- Publication year
- Publication venue
- Scientia Pharmaceutica
External Links
Snippet
Many bead biopharmaceutical characteristics are dependent on the bead shape. Furthermore, the shape is one of crucial parameters for incorporation of beads in more complex drug delivery system. Therefore, the aim of this study was to evaluate the influence …
- 239000011324 bead 0 title abstract description 110
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Smrdel et al. | The influence of selected parameters on the size and shape of alginate beads prepared by ionotropic gelation | |
| Faidi et al. | Application of sodium alginate extracted from a Tunisian brown algae Padina pavonica for essential oil encapsulation: Microspheres preparation, characterization and in vitro release study | |
| Pasparakis et al. | Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate–chitosan beads | |
| Fundueanu et al. | Preparation and characterization of Ca-alginate microspheres by a new emulsification method | |
| Sinha et al. | Chitosan microspheres as a potential carrier for drugs | |
| Galeska et al. | Controlled release of dexamethasone from PLGA microspheres embedded within polyacid-containing PVA hydrogels | |
| NUNTHANID | Calcium pectinate gel beads for controlled release drug delivery: II. Effect of form ulation and processing variables on drug release | |
| Bodmeier et al. | Spherical agglomerates of water‐insoluble drugs | |
| Veronovski et al. | Characterisation of biodegradable pectin aerogels and their potential use as drug carriers | |
| Filipović-Grčić et al. | Chitosan microspheres of nifedipine and nifedipine-cyclodextrin inclusion complexes | |
| Tavakol et al. | Sulfasalazine release from alginate-N, O-carboxymethyl chitosan gel beads coated by chitosan | |
| Hua et al. | pH-sensitive sodium alginate/poly (vinyl alcohol) hydrogel beads prepared by combined Ca2+ crosslinking and freeze-thawing cycles for controlled release of diclofenac sodium | |
| Mateovic et al. | The influence of stirring rate on biopharmaceutical properties of Eudragit RS microspheres | |
| Caballero et al. | Characterization of alginate beads loaded with ibuprofen lysine salt and optimization of the preparation method | |
| Niknia et al. | Gum tragacanth-polyvinyl alcohol cryogel and xerogel blends for oral delivery of silymarin: Structural characterization and mucoadhesive property | |
| US12102735B2 (en) | Biocompatible hydrogel, process for producing same, and use thereof in a mechanical viscosupplementation system | |
| Veronovski et al. | Comparison of ionic and non-ionic drug release from multi-membrane spherical aerogels | |
| Boppana et al. | Carboxymethylcellulose-aluminum hydrogel microbeads for prolonged release of simvastatin | |
| Armutcu et al. | Evaluation of controlled hydroxychloroquine releasing performance from calcium-alginate beads | |
| López-Cacho et al. | Robust Optimization of Alginate‐Carbopol 940 Bead Formulations | |
| Mirek et al. | Formation of disaggregated polymer microspheres by a novel method combining pulsed voltage electrospray and wet phase inversion techniques | |
| Singla et al. | Nifedipine loaded chitosan microspheres: characterization of internal structure | |
| Park et al. | Ca-alginate microspheres encapsulated in chitosan beads | |
| Ansary et al. | Preparation, characterization and antifungal activity studies of AgNPs loaded silk fibroin hydrogels | |
| Harilall et al. | Design and pharmaceutical evaluation of a nano-enabled crosslinked multipolymeric scaffold for prolonged intracranial release of zidovudine |